William L. Murphy, PHD
Position title: Professor, Biomedical Engineering, Orthopedics & Rehabilitation
Email: wlmurphy@wisc.edu
Phone: 608-265-9978
- Organ System/Disease Focus:
- Orthopedic and cardiovascular
- Aligned Research Focus:
- Tissue engineering, controlled stem cell culture
News Releases:
- Science and Serendipity: How Apples Are Laying the Foundation for Regenerating Bone
- William Murphy receives mid career Kellett award
- Quarterly Magazine by the Wisconsin Medical Alumni Association
- mRNA technology used in COVID vaccines now being tested to treat cancer, autoimmune diseases
More information:
- Bioinspired Materials Laboratory, Murphy group
Research Description:
In the Bioinspired Materials Laboratory, we are interested in developing “smart” biomaterials that mimic the complex signaling environments of natural tissue development. We place particular emphasis on temporal and spatial control over growth factor activity, gene transfer, and mechanical stimulation.
The materials developed in our lab are then used to understand and control stem cell differentiation, ultimately geared towards directed regeneration of a variety of human tissues. Our group is highly interdisciplinary, with research areas ranging from novel materials design approaches to basic stem cell biology.
Selected References:
- Aisenbrey, W.L. Murphy. Synthetic alternatives to Matrigel. Nature Reviews Materials, 2020; 5: 539-551.
- S. Khalil, X.Yu, J.M. Umhoefer, G.M. Diarrad, T.A. Hacker, W.L. Murphy. Single dose mRNA therapy via biomaterial-mediated sequestration of overexpressed proteins. Science Advances, 2020; 6: eaba2422.
- Kaushik, K. Gupta, V. Harms, E. Torr, J. Evans, H.J. Johnson, C. Soref, S. Acevedo-Acevedo, J. Antosiewicz-Bourget, D. Mamott, P. Uhl, B.P. Johnson, S.P. Palecek, D.J. Beebe, J.A. Thomson, W.T. Daly, W.L. Murphy. Engineered perineural vascular plexus for modeling developmental toxicity. Advanced Healthcare Materials, 2020;9:e2000825.
- Aisenbrey, E. Torr, H. Johnson, C. Soref, W. Daly, W.L. Murphy. A protocol for rapid pericyte differentiation of human induced pluripotent stem cells. STAR Protocols, 2021; 2: 100261.
- W. Xie, N.A. Zacharias, W.L. Murphy. Controlled aggregation enhances immunomodulatory potential of mesenchymal stromal cell aggregates. Stem Cells Translational Medicine, 2021; 10: 1184-1201.